Oup Management Co., LLC Cyteir Therapeutics, Inc. Transaction History

Oup Management Co., LLC

$44.5 Million
Q3 2023

A detailed history of Oup Management Co., LLC transactions in Cyteir Therapeutics, Inc. stock. As of the latest transaction made, Oup Management Co., LLC holds 2,459,572 shares of CYT stock, worth $7.4 Million. This represents 15.71% of its overall portfolio holdings.

Number of Shares

2,459,572

Previous 2,459,572 -0.0%

Holding current value

$7.4 Million

Previous $6.39 Million 9.24%

% of portfolio

15.71%

Previous 10.91%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$1.18 - $1.76 $11,800 - $17,600	-10,000 Reduced 0.4%	2,459,572 $4.06 Million
Q3 2022 Oct 31, 2022	SELL	$1.99 - $4.05 $9,950 - $20,250	-5,000 Reduced 0.2%	2,469,572 $4.74 Million
Q4 2021 Feb 03, 2022	BUY	$9.83 - $19.21 $24.3 Million - $47.5 Million	2,474,572 New	2,474,572 $28.1 Million

Others Institutions Holding CYT

# of Institutions

Shares Held

2.47M

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

15K
Shares

$45,150
0.04% of portfolio

View Full List

About Cyteir Therapeutics, Inc.

Ticker CYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,413,400
Market Cap $107M
Description
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...

More about CYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oup Management Co., LLC with notifications on news.

Account

Oup Management Co., LLC Cyteir Therapeutics, Inc. Transaction History